Purchase 5F-ADB
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 5F-ADB for sale
5F-ADB (5F-MDMB-PINACA) is a potent cannabinoid agonist from the indazole-3-carboxamide family. 5F-ADB is a synthetic cannabinoid and has been used as an active ingredient in synthetic cannabis products and sold online as a designer drug. It was first identified in post-mortem samples taken from an individual who had died after using a product containing this substance. Subsequent testing identified 5F-ADB to have been present in ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014.
5F-ADB is a potent, selective CB1 receptor agonist with a N-(piperidin-1-yl)indazole structure. 5F-ADB is an indazole-based synthetic cannabinoid that mimics the structure of Δ8THC. 5F-ADB was first identified in November 2014 in post-mortem samples taken from an individual who had died after using a product containing this substance.
5F-ADB (also known as 5F-MDMB-PINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family, which has been used as an active ingredient in synthetic cannabis products and has been sold online as a designer drug. 5F-ADB is a potent agonist of the CB1 receptor, though it is unclear whether it is selective for this target.
5F-ADB is a derivative of the earlier synthetic cannabinoid drug 5F-MDMB-PINACA, where the pinacol ester has been replaced with an amide. It is very potent at the CB1 receptor and was detected in tissue samples from several fatal cases of unexplained overdoses. 5F-ADB appears to be significantly more toxic than similar drugs, and there have been reports of death following recreational use.
5F-ADB is a derivative of the earlier synthetic cannabinoid drug 5F-MDMB-PINACA. 5F-ADB is considered to be one of the most potent drugs of its kind. There have been many reports of death in people using it recreationally.
5F-ADB (also known as 5F-MDMB-PINACA) is an extremely potent synthetic cannabinoid drug associated with many fatalities.
5F-ADB is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family. It is believed to be extremely potent based on low levels detected in tissue samples. It appears to be significantly more toxic than earlier synthetic cannabinoid drugs that had previously been sold.
5F-ADB is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family. It is known to be extremely potent and significantly more toxic than earlier synthetic cannabinoids previously sold.
5F-ADB is an indazole-based synthetic cannabinoid that acts as a potent agonist for the CB1 receptor and is first identified in early 2015. It is believed to be much more toxic than previously encountered synthetic cannabinoid drugs, producing severe side effects and fatalities in overdose situations.
5F-ADB is a synthetic drug most commonly known by its full name, 5F-ADB. It is a potent cannabinoid that is significantly more toxic than other cannabinoids.
5F-ADB is a synthetic cannabinoid that researchers in the 1960s first synthesized. It was not used for human consumption until 2013, when it was sold as a designer drug for synthetic cannabis products.
The chemical formula for 5F-ADB is C20H22FN3O. It is a synthetically created hybrid of JWH-018 and MAM-2201, often called 'spice,' that was first detected in Sydney, New South Wales, on May 18th and 19th, 2013.
Synthetic cannabinoids are chemicals related to natural cannabinoids (such as the active ingredient in marijuana) that produce similar effects. They are usually smoked or vaporized in e-cigarettes and often laced with other intoxicants, such as marijuana and tobacco.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
out of stock
100g $510
100g $490
100g $550
out of stock
1kg $1890
100g $580
100g $600
500g $1080
200g $590
out of stock
500g $1199